Compare iShares Core MSCI EAFE ETF (IEFA) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Core MSCI EAFE ETF vs Medtronic PLC — how do they compare? iShares Core MSCI EAFE ETF trades at $96.52 (market cap $189.19B), while Medtronic PLC trades at $88.48 (market cap $112.24B). The key difference: iShares Core MSCI EAFE ETF is the larger of the two by market cap, and Medtronic PLC pays a 3.28% dividend while iShares Core MSCI EAFE ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares Core MSCI EAFE ETF for 40 Days and Medtronic PLC for 63 Days on average.
| IEFA | MDT | |
|---|---|---|
Market Cap | $189.19B | $112.24B |
Volume | 8,441,787 | 105,663,236 |
Sector | Broad Market / Factor | Health |
52-Week High | $101.41 | $105.35 |
52-Week Low | $85.06 | $73.75 |
Typical Hold Time | 40 Days | 63 Days |
Enterprise Value | — | $131.58B |
Dividend Yield | — | 3.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IEFA (iShares Core MSCI EAFE ETF) trades at $95.87, down 0.34% with bearish technical signals dominating. The ETF manages $196 billion in assets and focuses on developed markets outside North America. Recent comparisons highlight its higher dividend yield versus competitors like Schwab's SCHF and State Street's SPDW, though some alternatives have shown stronger recent performance.
The outlook remains cautious given bearish technical indicators and competitive pressure from lower-cost alternatives. Key risks include international market volatility and currency fluctuations, while the fund's scale and diversification provide stability for long-term international exposure seekers.
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong fundamental performance including three consecutive quarterly earnings beats and a 49-year dividend growth streak. The stock shows bearish technical signals but maintains solid profitability with 13.93% net margins and positive cash flow trends. Recent regulatory approvals for medical devices and raised guidance signal operational momentum despite mixed technical indicators.
Outlook remains positive with analyst consensus at $97.80 (11% upside) and no sell ratings, though technical weakness and increasing debt-to-asset ratios pose near-term risks. The 3.2% dividend yield provides income support while revenue growth acceleration to $37.5B projected for 2026 offers growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Core MSCI EAFE ETF
IEFA tracks the MSCI EAFE Investable Market Index, offering broad exposure to large, mid, and small-cap stocks in developed markets across Europe, Australasia, and the Far East. It serves as a low-cost core holding for international diversification, excluding the U.S. and Canada.
Read more on IEFA →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
